Bristol-Myers Squibb
BMY
$44.03
Share price
-0.18%
Change (1 day)
-33.82%
Change (1 year)
Categories
Bristol-Myers Squibb (BMY) Fails to deliver data
Key failure to deliver metrics for Bristol-Myers Squibb:
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: $4.62 M
- Last 3 months FTD volume: $0.23 B
- Last year FTD volume: $0.32 B
Failures to deliver for Bristol-Myers Squibb (BMY) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Bristol-Myers Squibb (BMY) - since 2013
Volume in USD (price x number of shares), data since 2013Bristol-Myers Squibb (BMY) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.23 B | 52.96% |
| 2023 | $0.15 B | -29.53% |
| 2022 | $0.22 B | 107.77% |
| 2021 | $0.10 B | -72.46% |
| 2020 | $0.38 B | -11.25% |
| 2019 | $0.43 B | 203.91% |
| 2018 | $0.14 B | -20.27% |
| 2017 | $0.17 B | 4.53% |
| 2016 | $0.17 B | -7.42% |
| 2015 | $0.18 B | 76.57% |
| 2014 | $0.10 B | 237.33% |
| 2013 | $31.21 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.13 B | $0.59 B | 🇺🇸 USA |
 Novartis NVS | $18.64 M | $83.53 M | 🇨🇭 Switzerland |
 Pfizer PFE | $10.32 M | $0.31 B | 🇺🇸 USA |
 AbbVie ABBV | $8.72 M | $79.91 M | 🇺🇸 USA |
 Eli Lilly LLY | $56.64 M | $0.12 B | 🇺🇸 USA |
 Amgen AMGN | $52.25 M | $0.21 B | 🇺🇸 USA |
 Sanofi SNY | $21.22 M | $52.23 M | 🇫🇷 France |
 Biogen BIIB | $22.53 M | $74.47 M | 🇺🇸 USA |
 Merck MRK | $6.57 M | $0.15 B | 🇺🇸 USA |
 AstraZeneca AZN | $88.62 M | $0.16 B | 🇬🇧 UK |